Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00005263 · ClinicalTrials.gov registry record
Postprandial Lipoproteins and Atherosclerosis
A clinical trial, sponsored by Columbia University.
- Completed
- Registry status
- 205
- Enrollment target
NCT00005263: Completed study, sponsored by Columbia University.
NCT00005263 is a clinical trial that has completed, run by Columbia University. The registered enrollment target is 205 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00005263 has completed, sponsored by Columbia University.
- COMPLETED
- Registry status
- 205 participants
- Enrollment target
Study Summary
To determine whether postprandial lipoproteins were associated with atherosclerosis, and if so, whether the association was statistically independent of that between fasting lipoproteins and atherosclerosis.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 205 participants |
| Start Date | 1990-07 |
| Est. Completion | 1995-11 |
What the finished NCT00005263 record still lists
NCT00005263 is an observational study that tracks outcomes without assigning an intervention. The registered 205 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT00005263 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00005263 about?
NCT00005263 is a clinical study titled "Postprandial Lipoproteins and Atherosclerosis". To determine whether postprandial lipoproteins were associated with atherosclerosis, and if so, whether the association was statistically independent of that between fasting lipoproteins and atherosclerosis.
What is the current status of trial NCT00005263?
This trial is currently completed. The enrollment target is 205 participants. The study started on 1990-07. Estimated completion is 1995-11.
Who is sponsoring clinical trial NCT00005263?
This trial is sponsored by Columbia University, which has 958 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03457493 · 205 participants · Phase 1
The University of Alabama At Birmingham (UAB) Neuroinflammation in Parkinson's Disease-TSPO- Positron Emission Tomography (PET) Substudy
- NCT05134857 · 205 participants · Phase 2
The Zonisamide and Reinforcement for Reducing Alcohol Use (ZARRA) Study
- NCT05181891 · 205 participants · Phase 2
Pharmaceutically-Enhanced Reinforcement for Reduced Alcohol and Smoking
- NCT05283811 · 205 participants · NA
Understanding Prefrontal and Medial Temporal Neuronal Responses to Algorithmic Cognitive Variables in Epilepsy Patients
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia